Section Arrow
LEGN.NASDAQ
- Legend Biotech Corp
Quotes are at least 15-min delayed:2024/06/12 03:50 EDT
Last
 44.25
-1.29 (-2.83%)
Day High 
45.37 
Prev. Close
45.54 
1-M High
46.94 
Volume 
1.38M 
Bid
44.24
Ask
44.25
Day Low
43.13 
Open
45.2 
1-M Low
38.6 
Market Cap 
8.30B 
Currency USD 
P/E -- 
%Yield
10-SMA 42.98 
20-SMA 43.32 
50-SMA 46.89 
52-W High 77.32 
52-W Low 38.6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.58/-0.47
Enterprise Value
8.63B
Balance Sheet
Book Value Per Share
6.39
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
285.14M
Operating Revenue Per Share
0.90
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.5163+0.0053+1.04%-- 
GERNGeron Corp5.09+0.05+0.99%-- 
NVAXNovavax16.725+0.72+4.50%-- 
SCPXScorpius Holdings0.1034-0.0028-2.64%-- 
IOVAIovance Biotherapeutics8.62+0.565+7.01%-- 
Quotes are at least 15-min delayed:2024/06/12 03:50 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.